Related Experiment Videos
Screening for prostate cancer. How can patients give informed consent?
1Family Medicine Centre, Queen Elizabeth Hospital, Montreal.
Canadian Family Physician Medecin De Famille Canadien
|November 1, 1993
Summary
Urologists widely support prostate cancer screening using digital rectal exams and PSA tests. However, informed consent is challenging due to complex and contradictory information, hindering effective patient understanding.
Area of Science:
- Urology
- Oncology
- Medical Ethics
Background:
- Growing enthusiasm among North American urologists for prostate cancer screening.
- Widespread endorsement of annual digital rectal examination (DRE).
- Prevalence of prostate-specific antigen (PSA) testing as a favored screening method.
Purpose of the Study:
- To highlight the critical need for informed consent in prostate cancer screening.
- To address the complexities and contradictions in information provided for informed consent.
- To examine the difficulties physicians face in delivering and patients face in understanding screening information.
Main Methods:
- Review of current urological screening practices.
- Analysis of information dissemination for informed consent.
- Assessment of patient comprehension challenges.
Main Results:
- Digital rectal examination and PSA testing are common screening methods.
- Informed consent is often not adequately obtained due to information complexity.
- Physicians and patients struggle with the contradictory and complex nature of screening data.
Conclusions:
- Prostate cancer screening requires informed consent, which is currently inadequate.
- The complexity of screening information presents a barrier to informed decision-making.
- Further strategies are needed to improve the delivery and understanding of information for informed consent in prostate cancer screening.